According to the Lupus Foundation of America, more than 1.5 million Americans suffer from the disease.
The illness affects about 4,000 Americans, 80 percent of whom are women.
A recent OMRF study is potentially paving the way for better preventive treatment options for African American patients.
Multiple studies have show the drug is not effective at treating COVID-19, and in some cases can even cause heart problems.
James received the award for her contributions to understanding systemic autoimmune diseases such as lupus and rheumatoid arthritis.
The findings will allow for more targeted treatment approaches.